Imricor Medical Systems: Funding, Investors & Team (Sep 2026)
Imricor Medical Systems develops magnetic resonance imaging (MRI) compatible electrophysiology tools for the treatment of cardiac arrhythmias. The company offers Vision MR EP Ablation Catheter that looks and performs as a conventional ablation catheter; and Horizon MR EP Recording System, which performs the recording and pacing function of conventional recording and pacing systems for use with MRI. Its products allow electrophysiologists to perform cardiac electrophysiology procedures in the MRI lab to image a patient's heart.
Imricor Medical Systems has raised $43.3M across 1 funding round on record, the most recent an undisclosed round of $43.3M announced in May 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Imricor Medical Systems Company Profile and Key Stats
Latest funding round on record: May 2026.
Imricor Medical Systems Funding Rounds
Imricor Medical Systems Founders and Leadership Team
Contact details for the Imricor Medical Systems team: 1 has a LinkedIn profile.
Start 14-day free trial →Imricor Medical Systems Funding Compared to Other Biotechnology Startups
Imricor Medical Systems' latest round of $43.3M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Imricor Medical Systems in Biotechnology and Minneapolis
Companies Similar to Imricor Medical Systems
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Imricor Medical Systems Funding FAQs
What does Imricor Medical Systems do?
Imricor Medical Systems develops magnetic resonance imaging (MRI) compatible electrophysiology tools for the treatment of cardiac arrhythmias. The company offers Vision MR EP Ablation Catheter that looks and performs as a conventional ablation catheter; and Horizon MR EP Recording System, which performs the recording and pacing function of conventional recording and pacing systems for use with MRI. Its products allow electrophysiologists to perform cardiac electrophysiology procedures in the MRI lab to image a patient's heart.
How much funding has Imricor Medical Systems raised?
Imricor Medical Systems has raised $43.3M across 1 round on record. The most recent is an undisclosed round of $43.3M announced in May 2026.
When did Imricor Medical Systems last raise funding?
Imricor Medical Systems' most recent funding round on record is an undisclosed round of $43.3M, announced in May 2026.
Who founded Imricor Medical Systems?
FundedIQ lists Steve Wedan (Founder) at Imricor Medical Systems.
Where is Imricor Medical Systems headquartered?
Imricor Medical Systems is based in Minneapolis, Minnesota, United States.
How many employees does Imricor Medical Systems have?
Imricor Medical Systems is in the 51-100 employee band.
How does Imricor Medical Systems' funding compare to other Biotechnology startups?
Imricor Medical Systems' latest round of $43.3M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Imricor Medical Systems Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Imricor Medical Systems is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.